Latest European Market News

Control Bionics progresses its scalable distributor-led model in North America, inks a strategic US partnership for iOS speech devices, and gains German reimbursement eligibility for NeuroNode, while managing cash flow amid NDIS delays.

Argent BioPharma secured a 48% stake in CannPal Animal Therapeutics, shipped its largest CannEpil® order to Ireland worth A$783,000, and filed a US provisional patent for its NanoBodies platform, underpinning its neuro-immune strategy and commercial growth.

Arafura Rare Earths has locked in binding cornerstone equity agreements worth approximately A$230 million, bolstering its path to a final investment decision for the Nolans Project. The company also acquired critical camp infrastructure and is progressing technology development and offtake negotiations amid supportive government frameworks.

PhosCo Ltd advances its Gasaat Phosphate Project with robust drilling results at KM and SAB deposits, confirming thick, high-grade mineralisation. Imminent maiden resource estimates and a significant new discovery at DOH underscore the project's growing global significance amid supply chain disruptions.

Orthocell’s latest Remplir™ Real World Evidence study reveals an 89.7% treatment success rate across 78 nerve repair procedures, reinforcing its clinical strength and fueling US and European market growth plans.

Albright Metals delivers strong high-grade gold results from its Golden Pike Project in Canada while boosting its balance sheet through a $1.8 million tenement sale to Catalyst Metals, sharpening its focus on high-impact assets.

AML3D has maintained a steady $2.2 million quarterly revenue run rate and secured $12.5 million in new orders during 3Q26, pushing its total orders for FY2026 to $29 million. The company is aggressively expanding its US manufacturing footprint and making initial inroads into UK and European defence markets.

Finico Pty Ltd, already holding 57.5% of DTI Group, has launched an on-market takeover offer for all remaining shares at 1.2 cents each, representing a 20% premium over the last close. The offer opens 29 April and closes 29 May 2026, with Shaw and Partners appointed to facilitate the purchases.

Zinc Mines Ireland (ASX: ZMI) has acquired Dutch metals tech firm Meclex, integrating its proprietary low-temperature hydrometallurgical processes into ZMI’s Kildare zinc project. The move aims to unlock critical mineral value and reduce environmental impact in European zinc and battery recycling markets.

Champion Iron has finalized its US$300 million acquisition of Norwegian iron ore producer Rana Gruber, securing over 92% ownership and setting sights on full integration and delisting. The deal enhances Champion's high-purity iron ore portfolio and strengthens its position in the green steel supply chain.

Little Green Pharma Ltd (ASX:LGP) has secured overwhelming shareholder approval from Cannatrek Ltd for its proposed acquisition scheme, advancing the transaction toward Federal Court approval and implementation by early May 2026.

Macallum New Energy has progressed its seismic exploration in the North Perth Basin with the Barberton 3D survey underway and Condor 2D survey approved, while appointing Greenwood Capital Partners to enhance its UK and European market presence.